Selected research
Industry Research
Medical Inhalation Anesthetics Industry Research Report 2026
Market perspective
The global Medical Inhalation Anesthetics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Inhalation Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Inhalation Anesthetics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Inhalation Anesthetics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Inhalation Anesthetics include Sandoz International GmbH (Novartis), Novartis AG, Lunan Pharmaceutical Group Co. Ltd., Jiangsu Hengrui Medicine Co. Ltd., Fresenius SE & Co., Baxter International Inc., AbbVie Inc., Troikaa Pharmaceuticals, Ltd and Piramal Enterprises Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Inhalation Anesthetics market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Inhalation Anesthetics Market by Company
Sandoz International GmbH (Novartis)
Novartis AG
Lunan Pharmaceutical Group Co. Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius SE & Co.
Baxter International Inc.
AbbVie Inc.
Troikaa Pharmaceuticals, Ltd
Piramal Enterprises Ltd.
Maruishi Pharmaceutical
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Abbott Laboratories
Medical Inhalation Anesthetics Segment by Type
Isoflurane
Nitrous Oxide
Sevoflurane
Halothane
Desflurane
Others
Medical Inhalation Anesthetics Segment by Application
Hospitals
Ambulatory Surgical Centres
Others
Medical Inhalation Anesthetics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Inhalation Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Inhalation Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Inhalation Anesthetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Inhalation Anesthetics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Inhalation Anesthetics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Inhalation Anesthetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Isoflurane
- Nitrous Oxide
- Sevoflurane
- Halothane
- Desflurane
- Others
Applications
- Hospitals
- Ambulatory Surgical Centres
- Others
Companies covered
- Sandoz International GmbH (Novartis)
- Novartis AG
- Lunan Pharmaceutical Group Co. Ltd.
- Jiangsu Hengrui Medicine Co. Ltd.
- Fresenius SE & Co.
- Baxter International Inc.
- AbbVie Inc.
- Troikaa Pharmaceuticals, Ltd
- Piramal Enterprises Ltd.
- Maruishi Pharmaceutical
- Hikma Pharmaceuticals PLC
- Halocarbon Products Corporation
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Inhalation Anesthetics Market Size (2021-2032)
- 2.2.2 Global Medical Inhalation Anesthetics Sales (2021-2032)
- 2.2.3 Global Medical Inhalation Anesthetics Market Average Price (2021-2032)
- 2.3 Medical Inhalation Anesthetics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Isoflurane
- 2.3.3 Nitrous Oxide
- 2.3.4 Sevoflurane
- 2.3.5 Halothane
- 2.3.6 Desflurane
- 2.3.7 Others
- 2.4 Medical Inhalation Anesthetics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Ambulatory Surgical Centres
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Inhalation Anesthetics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Inhalation Anesthetics Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Medical Inhalation Anesthetics Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Inhalation Anesthetics Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Inhalation Anesthetics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Inhalation Anesthetics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Inhalation Anesthetics, Product Type & Application
- 3.8 Global Manufacturers of Medical Inhalation Anesthetics, Established Date
- 3.9 Global Medical Inhalation Anesthetics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sandoz International GmbH (Novartis)
- 4.1.1 Sandoz International GmbH (Novartis) Company Information
- 4.1.2 Sandoz International GmbH (Novartis) Business Overview
- 4.1.3 Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sandoz International GmbH (Novartis) Medical Inhalation Anesthetics Product Portfolio
- 4.1.5 Sandoz International GmbH (Novartis) Recent Developments
- 4.2 Novartis AG
- 4.2.1 Novartis AG Company Information
- 4.2.2 Novartis AG Business Overview
- 4.2.3 Novartis AG Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis AG Medical Inhalation Anesthetics Product Portfolio
- 4.2.5 Novartis AG Recent Developments
- 4.3 Lunan Pharmaceutical Group Co. Ltd.
- 4.3.1 Lunan Pharmaceutical Group Co. Ltd. Company Information
- 4.3.2 Lunan Pharmaceutical Group Co. Ltd. Business Overview
- 4.3.3 Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lunan Pharmaceutical Group Co. Ltd. Medical Inhalation Anesthetics Product Portfolio
- 4.3.5 Lunan Pharmaceutical Group Co. Ltd. Recent Developments
- 4.4 Jiangsu Hengrui Medicine Co. Ltd.
- 4.4.1 Jiangsu Hengrui Medicine Co. Ltd. Company Information
- 4.4.2 Jiangsu Hengrui Medicine Co. Ltd. Business Overview
- 4.4.3 Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangsu Hengrui Medicine Co. Ltd. Medical Inhalation Anesthetics Product Portfolio
- 4.4.5 Jiangsu Hengrui Medicine Co. Ltd. Recent Developments
- 4.5 Fresenius SE & Co.
- 4.5.1 Fresenius SE & Co. Company Information
- 4.5.2 Fresenius SE & Co. Business Overview
- 4.5.3 Fresenius SE & Co. Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fresenius SE & Co. Medical Inhalation Anesthetics Product Portfolio
- 4.5.5 Fresenius SE & Co. Recent Developments
- 4.6 Baxter International Inc.
- 4.6.1 Baxter International Inc. Company Information
- 4.6.2 Baxter International Inc. Business Overview
- 4.6.3 Baxter International Inc. Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter International Inc. Medical Inhalation Anesthetics Product Portfolio
- 4.6.5 Baxter International Inc. Recent Developments
- 4.7 AbbVie Inc.
- 4.7.1 AbbVie Inc. Company Information
- 4.7.2 AbbVie Inc. Business Overview
- 4.7.3 AbbVie Inc. Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AbbVie Inc. Medical Inhalation Anesthetics Product Portfolio
- 4.7.5 AbbVie Inc. Recent Developments
- 4.8 Troikaa Pharmaceuticals, Ltd
- 4.8.1 Troikaa Pharmaceuticals, Ltd Company Information
- 4.8.2 Troikaa Pharmaceuticals, Ltd Business Overview
- 4.8.3 Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Troikaa Pharmaceuticals, Ltd Medical Inhalation Anesthetics Product Portfolio
- 4.8.5 Troikaa Pharmaceuticals, Ltd Recent Developments
- 4.9 Piramal Enterprises Ltd.
- 4.9.1 Piramal Enterprises Ltd. Company Information
- 4.9.2 Piramal Enterprises Ltd. Business Overview
- 4.9.3 Piramal Enterprises Ltd. Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Piramal Enterprises Ltd. Medical Inhalation Anesthetics Product Portfolio
- 4.9.5 Piramal Enterprises Ltd. Recent Developments
- 4.10 Maruishi Pharmaceutical
- 4.10.1 Maruishi Pharmaceutical Company Information
- 4.10.2 Maruishi Pharmaceutical Business Overview
- 4.10.3 Maruishi Pharmaceutical Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Maruishi Pharmaceutical Medical Inhalation Anesthetics Product Portfolio
- 4.10.5 Maruishi Pharmaceutical Recent Developments
- 4.11 Hikma Pharmaceuticals PLC
- 4.11.1 Hikma Pharmaceuticals PLC Company Information
- 4.11.2 Hikma Pharmaceuticals PLC Business Overview
- 4.11.3 Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hikma Pharmaceuticals PLC Medical Inhalation Anesthetics Product Portfolio
- 4.11.5 Hikma Pharmaceuticals PLC Recent Developments
- 4.12 Halocarbon Products Corporation
- 4.12.1 Halocarbon Products Corporation Company Information
- 4.12.2 Halocarbon Products Corporation Business Overview
- 4.12.3 Halocarbon Products Corporation Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Halocarbon Products Corporation Medical Inhalation Anesthetics Product Portfolio
- 4.12.5 Halocarbon Products Corporation Recent Developments
- 4.13 Abbott Laboratories
- 4.13.1 Abbott Laboratories Company Information
- 4.13.2 Abbott Laboratories Business Overview
- 4.13.3 Abbott Laboratories Medical Inhalation Anesthetics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Abbott Laboratories Medical Inhalation Anesthetics Product Portfolio
- 4.13.5 Abbott Laboratories Recent Developments
5 Global Medical Inhalation Anesthetics Market Scenario by Region
- 5.1 Global Medical Inhalation Anesthetics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Inhalation Anesthetics Sales by Region: 2021-2032
- 5.2.1 Global Medical Inhalation Anesthetics Sales by Region: 2021-2026
- 5.2.2 Global Medical Inhalation Anesthetics Sales by Region: 2027-2032
- 5.3 Global Medical Inhalation Anesthetics Revenue by Region: 2021-2032
- 5.3.1 Global Medical Inhalation Anesthetics Revenue by Region: 2021-2026
- 5.3.2 Global Medical Inhalation Anesthetics Revenue by Region: 2027-2032
- 5.4 North America Medical Inhalation Anesthetics Market Facts & Figures by Country
- 5.4.1 North America Medical Inhalation Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 5.4.3 North America Medical Inhalation Anesthetics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Inhalation Anesthetics Market Facts & Figures by Country
- 5.5.1 Europe Medical Inhalation Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 5.5.3 Europe Medical Inhalation Anesthetics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Inhalation Anesthetics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Inhalation Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Inhalation Anesthetics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Inhalation Anesthetics Market Facts & Figures by Country
- 5.7.1 South America Medical Inhalation Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 5.7.3 South America Medical Inhalation Anesthetics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Medical Inhalation Anesthetics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Inhalation Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Inhalation Anesthetics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Inhalation Anesthetics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Inhalation Anesthetics Sales by Type (2021-2032)
- 6.1.1 Global Medical Inhalation Anesthetics Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Medical Inhalation Anesthetics Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Inhalation Anesthetics Revenue by Type (2021-2032)
- 6.2.1 Global Medical Inhalation Anesthetics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Inhalation Anesthetics Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Inhalation Anesthetics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Inhalation Anesthetics Sales by Application (2021-2032)
- 7.1.1 Global Medical Inhalation Anesthetics Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Medical Inhalation Anesthetics Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Inhalation Anesthetics Revenue by Application (2021-2032)
- 7.2.1 Global Medical Inhalation Anesthetics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Inhalation Anesthetics Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Inhalation Anesthetics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Inhalation Anesthetics Value Chain Analysis
- 8.1.1 Medical Inhalation Anesthetics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Inhalation Anesthetics Production Mode & Process
- 8.2 Medical Inhalation Anesthetics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Inhalation Anesthetics Distributors
- 8.2.3 Medical Inhalation Anesthetics Customers
9 Global Medical Inhalation Anesthetics Analyzing Market Dynamics
- 9.1 Medical Inhalation Anesthetics Industry Trends
- 9.2 Medical Inhalation Anesthetics Industry Drivers
- 9.3 Medical Inhalation Anesthetics Industry Opportunities and Challenges
- 9.4 Medical Inhalation Anesthetics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst